Developing an analog therapy for necrotic skin disease.
Industry: Health Care
First Day Return: n/a
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/13/2019 |
Offer Price | $4.00 |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $19 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/01/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $19 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Hanover, MD, United States |
Founded | 2011 |
Employees at IPO | 14 |
Website www.processapharmaceuticals.com |